Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
- PMID: 17502596
- PMCID: PMC1885574
- DOI: 10.1073/pnas.0702854104
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
Abstract
Ascorbate (ascorbic acid, vitamin C), in pharmacologic concentrations easily achieved in humans by i.v. administration, selectively kills some cancer cells but not normal cells. We proposed that pharmacologic ascorbate is a prodrug for preferential steady-state formation of ascorbate radical (Asc(*-)) and H(2)O(2) in the extracellular space compared with blood. Here we test this hypothesis in vivo. Rats were administered parenteral (i.v. or i.p.) or oral ascorbate in typical human pharmacologic doses ( approximately 0.25-0.5 mg per gram of body weight). After i.v. injection, ascorbate baseline concentrations of 50-100 microM in blood and extracellular fluid increased to peaks of >8 mM. After i.p. injection, peaks approached 3 mM in both fluids. By gavage, the same doses produced ascorbate concentrations of <150 microM in both fluids. In blood, Asc(*-) concentrations measured by EPR were undetectable with oral administration and always <50 nM with parenteral administration, even when corresponding ascorbate concentrations were >8 mM. After parenteral dosing, Asc(*-) concentrations in extracellular fluid were 4- to 12-fold higher than those in blood, were as high as 250 nM, and were a function of ascorbate concentrations. By using the synthesized probe peroxyxanthone, H(2)O(2) in extracellular fluid was detected only after parenteral administration of ascorbate and when Asc(*-) concentrations in extracellular fluid exceeded 100 nM. The data show that pharmacologic ascorbate is a prodrug for preferential steady-state formation of Asc(*-) and H(2)O(2) in the extracellular space but not blood. These data provide a foundation for pursuing pharmacologic ascorbate as a prooxidant therapeutic agent in cancer and infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1885574/bin/zpq0190762780001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1885574/bin/zpq0190762780002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1885574/bin/zpq0190762780003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1885574/bin/zpq0190762780004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1885574/bin/zpq0190762780005.gif)
Similar articles
-
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.Antioxid Redox Signal. 2013 Dec 10;19(17):2141-56. doi: 10.1089/ars.2013.5372. Epub 2013 Jun 19. Antioxid Redox Signal. 2013. PMID: 23621620 Free PMC article. Review.
-
Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.Adv Nutr. 2011 Mar;2(2):78-88. doi: 10.3945/an.110.000109. Epub 2011 Mar 10. Adv Nutr. 2011. PMID: 22332036 Free PMC article. Review.
-
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects.Free Radic Biol Med. 2009 Jul 1;47(1):32-40. doi: 10.1016/j.freeradbiomed.2009.02.016. Epub 2009 Feb 28. Free Radic Biol Med. 2009. PMID: 19254759
-
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. doi: 10.1073/pnas.0804226105. Epub 2008 Aug 4. Proc Natl Acad Sci U S A. 2008. PMID: 18678913 Free PMC article. Clinical Trial.
-
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9. doi: 10.1073/pnas.0506390102. Epub 2005 Sep 12. Proc Natl Acad Sci U S A. 2005. PMID: 16157892 Free PMC article.
Cited by
-
Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action.Front Nutr. 2024 Jan 11;10:1281879. doi: 10.3389/fnut.2023.1281879. eCollection 2023. Front Nutr. 2024. PMID: 38274206 Free PMC article. Review.
-
No-ozone cold plasma induces apoptosis in human neuroblastoma cell line via increased intracellular reactive oxygen species (ROS).BMC Complement Med Ther. 2024 Jan 20;24(1):46. doi: 10.1186/s12906-023-04313-0. BMC Complement Med Ther. 2024. PMID: 38245726 Free PMC article.
-
A Bioinspired Flexible Sensor for Electrochemical Probing of Dynamic Redox Disequilibrium in Cancer Cells.Adv Sci (Weinh). 2023 Dec;10(36):e2304079. doi: 10.1002/advs.202304079. Epub 2023 Nov 9. Adv Sci (Weinh). 2023. PMID: 37943018 Free PMC article.
-
Stability of aqueous solutions of ascorbate for basic research and for intravenous administration.Adv Redox Res. 2023 Dec;9:100077. doi: 10.1016/j.arres.2023.100077. Epub 2023 Jul 16. Adv Redox Res. 2023. PMID: 37808406 Free PMC article.
-
Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage.Antioxidants (Basel). 2023 Sep 18;12(9):1775. doi: 10.3390/antiox12091775. Antioxidants (Basel). 2023. PMID: 37760080 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous